Victoria Atkinson
- Co-authors
- Georgina V. LongPaolo A. AsciertoCaroline RobertRahul LadwaReinhard DummerAlexander M. MenziesJames LarkinMario Mandalà
- Topics
- Cancer Immunotherapy and Biomarkers (20 papers)Melanoma and MAPK Pathways (20 papers)CAR-T cell therapy research (18 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Victoria Atkinson
40 papers receiving 578 citations
Peers
Comparison fields: 5 of 52
- Oncology 480
- Molecular Biology 270
- Immunology 181
- Pulmonary and Respiratory Medicine 109
- Surgery 47
Countries citing papers authored by Victoria Atkinson
This map shows the geographic impact of Victoria Atkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Atkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Atkinson more than expected).
Fields of papers citing papers by Victoria Atkinson
This network shows the impact of papers produced by Victoria Atkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Atkinson. The network helps show where Victoria Atkinson may publish in the future.
Co-authorship network of co-authors of Victoria Atkinson
This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Atkinson. A scholar is included among the top collaborators of Victoria Atkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Atkinson. Victoria Atkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 16 | |
| 4 | 50 | |
| 5 | 14 | |
| 6 | 1 | |
| 7 | 30 | |
| 8 | 25 | |
| 9 | 3 | |
| 10 | 19 | |
| 11 | 4 | |
| 12 | 12 | |
| 13 | 85 | |
| 14 | Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Updated results from a phase 3 trial (CheckMate 238) | 1 |
| 15 | 3 | |
| 16 | 21 | |
| 17 | 3 | |
| 18 | Pembrolizumab for Metastatic Melanoma: Results of the Complete Responders On the Named Patient Access Program | 1 |
| 19 | 89 | |
| 20 | 1 |
About Victoria Atkinson
Victoria Atkinson is a scholar working on Oncology, Immunology and Genetics, having authored 41 papers that have together received 591 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Melanoma and MAPK Pathways (20 papers) and CAR-T cell therapy research (18 papers). The work is most often cited by research in Oncology (480 citations), Immunology (181 citations) and Molecular Biology (270 citations). Victoria Atkinson has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Georgina V. Long, Paolo A. Ascierto, Caroline Robert, Rahul Ladwa, Reinhard Dummer, Alexander M. Menzies, James Larkin, Mario Mandalà, Vanna Chiarion‐Sileni and Richard Kefford. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.